This announcement is a separate document:
貝康醫療-B：須予披露及關連交易 出售星博生物35%的股權
BASECARE-B: DISCLOSEABLE AND CONNECTED TRANSACTION DISPOSAL OF 35% EQUITY INTEREST IN CELLPRO BIOTECH
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.